Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure Appointed director
|
Prevail Therapeutics Inc. (PRVL)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/12/2021 |
GN
| INVESTIGATION ALERT: Halper Sadeh LLP Investigates BPFH, MDCA, MTSC, PRVL; Shareholders Are Encouraged to Contact the Firm |
01/07/2021 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLNX, ANH, TCF, PRVL; Shareholders Are Encouraged to Contact the Firm |
12/19/2020 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – ANH, TCF, PRVL, ZAGG |
12/16/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Prevail Therapeutics Inc. Buyout |
12/16/2020 |
GN
| PREVAIL THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRVL and Encourages Investors to Contact the Firm |
12/11/2020 |
GN
| Prevail Therapeutics Announces First Patient Dosed in Phase 1/2 PROCLAIM Clinical Trial Evaluating PR006 for the Treatment of Frontotemporal Dementia Patients with GRN Mutations |
11/18/2020 |
GN
| Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001 |
11/10/2020 |
GN
| Prevail Therapeutics to Present at Upcoming Investor Conferences |
09/25/2020 |
GN
| Prevail Therapeutics to Present at Upcoming Investor Conferences |
09/18/2020 |
GN
| Prevail Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit |
09/02/2020 |
GN
| Prevail Therapeutics to Present at Upcoming Investor Conferences |
08/11/2020 |
GN
| Prevail Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights |
08/05/2020 |
GN
| Prevail Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Conference |
07/27/2020 |
GN
| Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR006 |
07/22/2020 |
GN
| Prevail Therapeutics to Highlight Multiple Gene Therapy Programs for Neurodegenerative Diseases at the Virtual 2020 Alzheimer's Association International Conference |
|
|